Cornea · 2002
Intracameral amphotericin B injection in the management of deep keratomycosis.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kuriakose Thomas, Kothari Mihir, Paul Padma, Jacob Pushpa, Thomas Ravi
Аннотация
PURPOSE: To report the use of intracameral amphotericin B in the management of deep keratomycosis.
METHODS: Four patients with deep keratomycosis unresponsive to conventional medical treatment underwent repeated intracameral injections of 5 microg amphotericin B in 0.1 mL 5% dextrose through a paracentesis. Three to 13 intracameral injections were given to each patient over 6 to 36 days.
RESULTS: Three of the four patients had complete resolution of the ulcer. The fourth patient perforated and required evisceration.
CONCLUSION: Preliminary experience suggests that intracameral injections of amphotericin B may have a role in the management of deep keratomycosis.
METHODS: Four patients with deep keratomycosis unresponsive to conventional medical treatment underwent repeated intracameral injections of 5 microg amphotericin B in 0.1 mL 5% dextrose through a paracentesis. Three to 13 intracameral injections were given to each patient over 6 to 36 days.
RESULTS: Three of the four patients had complete resolution of the ulcer. The fourth patient perforated and required evisceration.
CONCLUSION: Preliminary experience suggests that intracameral injections of amphotericin B may have a role in the management of deep keratomycosis.